Skip to main content
Equibles

Apollon Wealth Management, LLC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1764387 MOUNT PLEASANT, SC
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$537,954
+$37,948 QoQ
Shares Held
6,595
-10.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#224
of 383 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Apollon Wealth Management, LLC holds $51,440,082 across 23 Biotechnology names. PTCT ranks #5 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 63,910 $31,746,014
2 BMRN
Biomarin Pharmaceutical Inc
 137,661 $7,876,962
3 REGN
Regeneron Pharmaceuticals, Inc.
 6,662 $4,154,023
4 RARE
Ultragenyx Pharmaceutical Inc.
 123,449 $4,121,962
5 PTCT
Ptc Therapeutics, Inc.
This page 		6,595 $537,954
6 CRSP
CRISPR Therapeutics AG
 8,350 $455,409
7 MRNA
Moderna, Inc.
 5,260 $368,357
8 HURA
TuHURA Biosciences, Inc./NV
 156,519 $366,254

All Filings in PTCT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $537,954 6,595
2026-03-31 $500,006 7,339
2025-12-31 $559,521 7,366
2025-09-30 $542,449 8,839
2025-06-30 $431,696 8,839
2025-03-31 $450,435 8,839
2024-12-31 $398,992 8,839
2024-09-30 $655,853 17,678
2024-06-30 $540,593 17,678
2024-03-31 $514,253 17,678
2023-12-31 $487,315 17,682
2023-09-30 $396,163 17,678
2023-06-30 $718,964 17,678